Omega-3 Supplementation & Behavior Problems

Status Completed

Clinical Trial Summary

The objectives of this project are as follows:

1. To assess whether omega-3 dietary supplementation for six months can reduce externalizing behavior problems (antisocial and aggressive behavior) in schoolchildren aged 8 to 18, both at the end of treatment and six months post-treatment

2. To assess whether omega-3 supplementation is more effective in children with more psychopathic-like traits.

Clinical Trial Description

Externalizing behavior problems (aggressive and antisocial behaviors) are widely recognized as predisposing to significant mental health problems and violence among adolescents in secondary schools. These in turn result in enormous economic and social costs to schools as well as to society. These costs include mental illness, crime, and violence. Similarly, violence is widely recognized as a major public health problem which has also largely defied successful intervention and prevention. Because an increasing body of research is documenting health and neurobiological risk factors for aggression and violence, part of this prevention failure may be due to intervention efforts ignoring biological contributory factors which include impaired neurocognitive and psychophysiological functioning. One benign biological intervention that may help attenuate behavior problems in children consists of omega-3 supplementation of the diet, a long-chain fatty acid critical for brain structure and function.

The overarching aim of this study is to assess whether omega-3 supplementation can reduce the base level of externalizing behavior problems in children and adolescents. A secondary but important aim is to assess whether any behavioral improvement may be greater in more psychopathic children. The specific aims are as follows:

1. To assess the effectiveness of omega-3 dietary supplementation in reducing externalizing behaviors in adolescents.

2. To assess whether omega-3 supplementation leads to greater improvement in children with psychopathic-like traits.

Hypotheses will be tested in a placebo-controlled, double-blind, randomized trial involving 8 to18 year-old adolescents drawn from primary and secondary schools in Hong Kong. Omega-3 supplementation will be in the form of a Norwegian fruit juice drink. 300 adolescents will be randomly assigned into: (1) omega-3 supplemented drink, (2) placebo drink, (3) treatment-as-usual controls. Behavioral measures will be assessed at baseline (0 months), end of treatment (6 months), and 6 months post-treatment (12 months). ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02334098
Study type	Interventional
Source	City University of Hong Kong
Contact
Status	Completed
Phase	Phase 2/Phase 3
Start date	February 2015
Completion date	July 2018

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02485587` - Arousal-Biofeedback for the Treatment of Aggressive Behavior in Children and Adolescents	N/A
Completed	`NCT02552147` - Nicotinic Cholinergic Modulation as a Novel Treatment Strategy for Aggression Associated With Autism	Phase 1
Active, not recruiting	`NCT01792167` - Multi-Site Evaluation of Second Step	N/A
Completed	`NCT00361062` - Aggressive Behavior Induced by Selective Serotonin Reuptake Inhibitors (SSRIs) During the First Month of Treatment	N/A
Completed	`NCT00455234` - Rapid Tranquillization Trial: TREC-India II	Phase 3
Completed	`NCT00000385` - Long-Term Lithium Treatment for Aggressive Conduct Disorder	Phase 3
Not yet recruiting	`NCT03672942` - Communication Skills vs. Mindfulness for IPV	N/A
Recruiting	`NCT04732052` - The Use of Transcranial Direct Current Stimulation (tDCS) in Adults With Developmental Disabilities	N/A
Terminated	`NCT02483572` - Treatment of Severe Destructive Behavior: FCT Versus Wait-List Control	N/A
Completed	`NCT04097431` - Identifying Precursors to Severe Problem Behavior	N/A
Completed	`NCT04130360` - A Trial of an Online Problem-solving Intervention for Aggression	N/A
Completed	`NCT02563145` - Real-time fMRI for the Treatment of Aggressive Behavior in Adolescents	N/A
Completed	`NCT00510094` - Effectiveness of Treatment for Relational Aggression in Urban African American Girls	Phase 3
Recruiting	`NCT03430973` - Aggressive Driving and Road Rage: A Driving Simulation Experiment.	N/A
Completed	`NCT03693209` - Using Implementation Intentions to Reduce Anger and Aggression in Adolescence	N/A
Recruiting	`NCT05543681` - IGC-AD1 Trial on Agitation in Dementia Due to Alzheimer's	Phase 2
Completed	`NCT03784846` - Mindfulness-Based Resilience Training for Aggression, Health, and Stress Among Law Enforcement Officers	N/A
Active, not recruiting	`NCT04204759` - Transcranial Direct Current Stimulation and Antisocial Behavior	N/A
Completed	`NCT06453070` - Hasan Kalyoncu University
Completed	`NCT01965184` - Cognitive-Behavioral Therapy for Disruptive Behavior in Children and Adolescents	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Omega-3 Supplementation and Behavior Problems

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms